We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Graham Corp
GHM
$1.22B
| $232K | ﹤0.01% |
6,405
| – | – |
|
|
RGT
802
Royce Global Value Trust
RGT
$95.8M
| $232K | ﹤0.01% |
+26,066
| New | +$226K |
|
803
Rand Capital
RAND
$30M
| $227K | ﹤0.01% |
8,250
-166
| -2% | -$4.43K |
|
804
Transcat
TRNS
$793M
| $227K | ﹤0.01% |
28,450
-7,505
| -21% | -$60.2K |
|
|
ETP
805
DELISTED
Energy Transfer Partners L.p.
ETP
| $227K | ﹤0.01% |
+3,960
| New | +$210K |
|
806
Ingredion
INGR
$6.38B
| $226K | ﹤0.01% |
+3,296
| New | +$223K |
|
807
Weyerhaeuser
WY
$17.3B
| $226K | ﹤0.01% |
+7,147
| New | +$214K |
|
|
BHI
808
DELISTED
Baker Hughes
BHI
| $219K | ﹤0.01% |
+3,966
| New | +$217K |
|
809
Bausch Health
BHC
$1.65B
| $218K | ﹤0.01% |
+1,860
| New | +$204K |
|
810
C.H. Robinson
CHRW
$22B
| $217K | ﹤0.01% |
3,722
-1,685
| -31% | -$99.1K |
|
811
Liberty Global Class A
LBTYA
$3.28B
| $217K | ﹤0.01% |
+5,912
| New | +$198K |
|
|
MRC
812
DELISTED
MRC Global
MRC
| $214K | ﹤0.01% |
+6,640
| New | +$200K |
|
|
K
813
DELISTED
Kellanova
K
| $213K | ﹤0.01% |
+3,712
| New | +$214K |
|
814
AMC Global Media
AMCX
$430M
| $212K | ﹤0.01% |
+3,104
| New | +$207K |
|
815
Equinor
EQNR
$95.9B
| $212K | ﹤0.01% |
+8,784
| New | +$203K |
|
816
Tennant Co
TNC
$1.5B
| $211K | ﹤0.01% |
+3,108
| New | +$198K |
|
|
SWY
817
DELISTED
SAFEWAY INC
SWY
| $211K | ﹤0.01% |
+7,231
| New | +$217K |
|
818
Ross Stores
ROST
$76.6B
| $210K | ﹤0.01% |
+5,622
| New | +$211K |
|
819
CBIZ
CBZ
$2.29B
| $209K | ﹤0.01% |
22,880
-10,200
| -31% | -$86K |
|
820
Madison Square Garden
MSGS
$9.54B
| $208K | ﹤0.01% |
+5,071
| New | +$206K |
|
|
CFN
821
DELISTED
CAREFUSION CORPORATION
CFN
| $208K | ﹤0.01% |
+5,219
| New | +$203K |
|
822
Telephone and Data Systems
TDS
$3.91B
| $206K | ﹤0.01% |
+7,983
| New | +$226K |
|
|
SCU
823
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $205K | ﹤0.01% |
1,388
+238
| +21% | +$31.4K |
|
|
BKSC
824
DELISTED
Bank of South Carolina
BKSC
| $205K | ﹤0.01% |
15,626
| – | – |
|
825
Santander
BSBR
$39.7B
| $204K | ﹤0.01% |
34,974
-60,030
| -63% | -$378K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.